Two Sigma Advisers’s Purple Biotech PPBT Stock Holding History

Two Sigma Advisers’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,470	Closed	-$9.66K	–	1604
2025 Q4	$9.66K	Buy	+1,470	New	+$10.7K	﹤0.01%	2326

Other funds holding PPBT

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SmartHarvest Portfolios Poulsbo, Washington $240M AUM

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Two Sigma Advisers's PPBT Position: Q1 2026 in Review

Two Sigma Advisers sold out of Purple Biotech (PPBT) in Q1 2026, closing a stake of 1,470 shares — an estimated $9.66K sold.

Two Sigma Advisers first reported a position in PPBT in Q4 2025 and held it in 1 quarter. The position peaked at $9.66K in Q4 2025. 15 funds tracked by Wall St. Rank hold PPBT as of Q1 2026.

Two Sigma Advisers reported no remaining Purple Biotech position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 1,470 Purple Biotech shares in Q1 2026, an estimated $9.66K.
Two Sigma Advisers first reported a position in Purple Biotech in Q4 2025 and held it in 1 quarter.
Two Sigma Advisers's Purple Biotech position peaked at $9.66K in Q4 2025.
15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.